BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34973084)

  • 1. Blocking GARP-mediated activation of TGF-β1 did not alter innate or adaptive immune responses to bacterial infection or protein immunization in mice.
    Gaignage M; Zhang X; Stockis J; Dedobbeleer O; Michiels C; Cochez P; Dumoutier L; Coulie PG; Lucas S
    Cancer Immunol Immunother; 2022 Aug; 71(8):1851-1862. PubMed ID: 34973084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies against GARP/TGF-β1 complexes inhibit the immunosuppressive activity of human regulatory T cells in vivo.
    Cuende J; Liénart S; Dedobbeleer O; van der Woning B; De Boeck G; Stockis J; Huygens C; Colau D; Somja J; Delvenne P; Hannon M; Baron F; Dumoutier L; Renauld JC; De Haard H; Saunders M; Coulie PG; Lucas S
    Sci Transl Med; 2015 Apr; 7(284):284ra56. PubMed ID: 25904740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of TGF-β1 produced by GARP-expressing Tregs overcomes resistance to PD-1/PD-L1 blockade in cancer.
    de Streel G; Bertrand C; Chalon N; Liénart S; Bricard O; Lecomte S; Devreux J; Gaignage M; De Boeck G; Mariën L; Van De Walle I; van der Woning B; Saunders M; de Haard H; Vermeersch E; Maes W; Deckmyn H; Coulie PG; van Baren N; Lucas S
    Nat Commun; 2020 Sep; 11(1):4545. PubMed ID: 32917858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking immunosuppression by human Tregs in vivo with antibodies targeting integrin αVβ8.
    Stockis J; Liénart S; Colau D; Collignon A; Nishimura SL; Sheppard D; Coulie PG; Lucas S
    Proc Natl Acad Sci U S A; 2017 Nov; 114(47):E10161-E10168. PubMed ID: 29109269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysosomal-associated Transmembrane Protein 4B (LAPTM4B) Decreases Transforming Growth Factor β1 (TGF-β1) Production in Human Regulatory T Cells.
    Huygens C; Liénart S; Dedobbeleer O; Stockis J; Gauthy E; Coulie PG; Lucas S
    J Biol Chem; 2015 Aug; 290(33):20105-16. PubMed ID: 26126825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic activity of GARP:TGF-β1 blockade in murine primary myelofibrosis.
    Lecomte S; Devreux J; de Streel G; van Baren N; Havelange V; Schröder D; Vaherto N; Vanhaver C; Vanderaa C; Dupuis N; Pecquet C; Coulie PG; Constantinescu SN; Lucas S
    Blood; 2023 Feb; 141(5):490-502. PubMed ID: 36322928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined Blockade of GARP:TGF-β1 and PD-1 Increases Infiltration of T Cells and Density of Pericyte-Covered GARP
    Bertrand C; Van Meerbeeck P; de Streel G; Vaherto-Bleeckx N; Benhaddi F; Rouaud L; Noël A; Coulie PG; van Baren N; Lucas S
    Front Immunol; 2021; 12():704050. PubMed ID: 34386010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the expression of GARP/latent TGF-β1 complexes on mouse T cells and their role in regulatory T cell and Th17 differentiation.
    Edwards JP; Fujii H; Zhou AX; Creemers J; Unutmaz D; Shevach EM
    J Immunol; 2013 Jun; 190(11):5506-15. PubMed ID: 23645881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of lysosome metabolism-meditated GARP/TGF-β1 complexes specifically depletes regulatory T cells to inhibit breast cancer metastasis.
    Ma J; Chen Y; Li T; Cao Y; Hu B; Liu Y; Zhang Y; Li X; Liu J; Zhang W; Niu H; Gao J; Zhang Z; Yue K; Wang J; Bao G; Wang C; Wang PG; Zou T; Xie S
    Oncogene; 2024 Jun; 43(25):1930-1940. PubMed ID: 38698265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GARP is regulated by miRNAs and controls latent TGF-β1 production by human regulatory T cells.
    Gauthy E; Cuende J; Stockis J; Huygens C; Lethé B; Collet JF; Bommer G; Coulie PG; Lucas S
    PLoS One; 2013; 8(9):e76186. PubMed ID: 24098777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of GARP in the activation of latent TGF-β1.
    Stockis J; Dedobbeleer O; Lucas S
    Mol Biosyst; 2017 Sep; 13(10):1925-1935. PubMed ID: 28795730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Garp as a therapeutic target for modulation of T regulatory cell function.
    Shevach EM
    Expert Opin Ther Targets; 2017 Feb; 21(2):191-200. PubMed ID: 28001437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic Stellate Cells Inhibit T Cells through Active TGF-β1 from a Cell Surface-Bound Latent TGF-β1/GARP Complex.
    Li Y; Kim BG; Qian S; Letterio JJ; Fung JJ; Lu L; Lin F
    J Immunol; 2015 Sep; 195(6):2648-56. PubMed ID: 26246140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutting Edge: Active TGF-β1 Released from GARP/TGF-β1 Complexes on the Surface of Stimulated Human B Lymphocytes Increases Class-Switch Recombination and Production of IgA.
    Dedobbeleer O; Stockis J; van der Woning B; Coulie PG; Lucas S
    J Immunol; 2017 Jul; 199(2):391-396. PubMed ID: 28607112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The GARP/Latent TGF-β1 complex on Treg cells modulates the induction of peripherally derived Treg cells during oral tolerance.
    Edwards JP; Hand TW; Morais da Fonseca D; Glass DD; Belkaid Y; Shevach EM
    Eur J Immunol; 2016 Jun; 46(6):1480-9. PubMed ID: 27062243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release of active TGF-β1 from the latent TGF-β1/GARP complex on T regulatory cells is mediated by integrin β8.
    Edwards JP; Thornton AM; Shevach EM
    J Immunol; 2014 Sep; 193(6):2843-9. PubMed ID: 25127859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis of latent TGF-β1 presentation and activation by GARP on human regulatory T cells.
    Liénart S; Merceron R; Vanderaa C; Lambert F; Colau D; Stockis J; van der Woning B; De Haard H; Saunders M; Coulie PG; Savvides SN; Lucas S
    Science; 2018 Nov; 362(6417):952-956. PubMed ID: 30361387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel GARP humanized mouse model for efficacy assessment of GARP-targeting therapies.
    Guo J; Niu Z; Lv R; Yuan J; Zhang Z; Guan X; Li D; Zhang H; Zhao A; Feng J; Liu D; Zhou X; Gong J
    Int Immunopharmacol; 2024 Mar; 130():111782. PubMed ID: 38442579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of GARP on mouse regulatory T cells is not sufficient to inhibit the growth of transplanted tumors.
    Vermeersch E; Liénart S; Collignon A; Lucas S; Gallimore A; Gysemans C; Unutmaz D; Vanhoorelbeke K; De Meyer SF; Maes W; Deckmyn H
    Cell Immunol; 2018 Oct; 332():129-133. PubMed ID: 30093071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin contributes to cancer immune evasion via proteolysis of platelet-bound GARP to activate LTGF-β.
    Metelli A; Wu BX; Riesenberg B; Guglietta S; Huck JD; Mills C; Li A; Rachidi S; Krieg C; Rubinstein MP; Gewirth DT; Sun S; Lilly MB; Wahlquist AH; Carbone DP; Yang Y; Liu B; Li Z
    Sci Transl Med; 2020 Jan; 12(525):. PubMed ID: 31915300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.